These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 12042878)

  • 21. Protease-activated receptors in neuronal development, neurodegeneration, and neuroprotection: thrombin as signaling molecule in the brain.
    Rohatgi T; Sedehizade F; Reymann KG; Reiser G
    Neuroscientist; 2004 Dec; 10(6):501-12. PubMed ID: 15534036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrovascular effects of oestrogen: multiplicity of action.
    Duckles SP; Krause DN
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):801-8. PubMed ID: 17600562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The female sex hormone oestrogen as neuroprotectant: activities at various levels.
    Behl C; Moosmann B; Manthey D; Heck S
    Novartis Found Symp; 2000; 230():221-34; discussion 234-8. PubMed ID: 10965511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of oestrogen receptor gene expression: new insights and novel mechanisms.
    Wilson ME; Westberry JM
    J Neuroendocrinol; 2009 Mar; 21(4):238-42. PubMed ID: 19207817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leptin as a neuroprotective agent.
    Tang BL
    Biochem Biophys Res Commun; 2008 Apr; 368(2):181-5. PubMed ID: 18222172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progesterone and progestins: neuroprotection and myelin repair.
    Schumacher M; Sitruk-Ware R; De Nicola AF
    Curr Opin Pharmacol; 2008 Dec; 8(6):740-6. PubMed ID: 18929681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-genomic vascular actions of female sex hormones: physiological implications and signalling pathways.
    Leung SW; Teoh H; Keung W; Man RY
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):822-6. PubMed ID: 17600565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).
    Schäbitz WR; Krüger C; Pitzer C; Weber D; Laage R; Gassler N; Aronowski J; Mier W; Kirsch F; Dittgen T; Bach A; Sommer C; Schneider A
    J Cereb Blood Flow Metab; 2008 Jan; 28(1):29-43. PubMed ID: 17457367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection.
    Cardona-Gómez GP; Mendez P; DonCarlos LL; Azcoitia I; Garcia-Segura LM
    Brain Res Brain Res Rev; 2001 Nov; 37(1-3):320-34. PubMed ID: 11744097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How estrogens will surprise us again?].
    Malinowska-Kołodziej I; Marcol W; Lewin-Kowalik J
    Wiad Lek; 2006; 59(7-8):527-33. PubMed ID: 17209353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor.
    Ohtake F; Takeyama K; Matsumoto T; Kitagawa H; Yamamoto Y; Nohara K; Tohyama C; Krust A; Mimura J; Chambon P; Yanagisawa J; Fujii-Kuriyama Y; Kato S
    Nature; 2003 May; 423(6939):545-50. PubMed ID: 12774124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional activation of the oxytocin promoter by oestrogens uses a novel non-classical mechanism of oestrogen receptor action.
    Koohi MK; Ivell R; Walther N
    J Neuroendocrinol; 2005 Apr; 17(4):197-207. PubMed ID: 15842231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oestrogen-receptors (ER) are likely to be promiscuous: wider role for oestrogens and mimics.
    Wiseman A
    Med Hypotheses; 2005; 65(4):760-5. PubMed ID: 15961252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neuroprotective effect of oestrogen on the central nervous system].
    Mariak Z; Rakowski G; Krejza J
    Przegl Lek; 2007; 64(12):1028-30. PubMed ID: 18595509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone induces neuroprotection from oxidative stress. Effects on catalase activity and 3-nitro-L-tyrosine incorporation into alpha-tubulin in a mouse neuroblastoma cell line.
    Chisu V; Manca P; Lepore G; Gadau S; Zedda M; Farina V
    Arch Ital Biol; 2006 May; 144(2):63-73. PubMed ID: 16642786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oestrogen: brain ageing, cognition and neuropsychiatric disorder.
    Norbury R; Craig M; Cutter WJ; Whitehead M; Murphy DG
    J Br Menopause Soc; 2004 Sep; 10(3):118-22. PubMed ID: 15494104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estradiol and neurodegenerative oxidative stress.
    Nilsen J
    Front Neuroendocrinol; 2008 Oct; 29(4):463-75. PubMed ID: 18275991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia.
    Liu X; Fan XL; Zhao Y; Luo GR; Li XP; Li R; Le WD
    J Neurosci Res; 2005 Sep; 81(5):653-65. PubMed ID: 16013043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.